


































Human cells exhibit a greatly enhanced stringency for 
growth control and greater genomic stability when 
compared to rodent cells [1]. This higher stringency is 
thought to underlie the relative resistance of humans to 
malignancies. For example, it has been estimated that 
the difference in the spontaneous immortalization rate 





-10 [2]. This difference is reflected 
experimentally in studies which introduced active 
oncogenes to drive malignant transformation in primary 
cells. Rodent cells required a single oncogenic mutation 
coupled with abrogation of the major cell cycle 
checkpoint regulator p53, while human cells required 
the addition of multiple oncogenic mutations targeting 
several intracellular pathways critical to cell cycle 
progression and survival, which include p53, pRb, and 
the Ras/MAPK pathway as well as cellular 
phosphatases  [3].   Substantial   differences  have  been  
 
 

































found at the cellular level that may contribute to the 
species-specific differences in genomic stability between 
rodent and human cells. For example, telomere biology 
differs significantly between rodent and human cells [4], 
and the spindle checkpoint has been found to be much 
less stable in rodent cells [5,6]. In addition, there is 
variation in essential DNA repair proteins such the 
Ku70/80 heterodimer and DNA end binding, although 
absolute DNA repair rates appear to be similar in rodents 
and humans as assessed by standard assays [7]. 
 
We have sought to further understand the differences in 
genomic stability between rodent and human cells by 
examining the formation of micronuclei, small 
membrane bound DNA fragments that form as a result 
of unresolved DNA damage, and the accumulation of 
53BP1 into DNA damage foci. We find that significant 
differences exist in both spontaneous and DNA 
damage-induced rates of micronuclei formation as well 































the  levels  and  recruitment  of  53BP1  in  mouse  and  human  cells  following  DNA  damage.  In  addition,  we  show  that
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DNA repair and cell cycle control are linked to 
micronuclei 
 
Due to its involvement in multiple genomic functions, 
we postulated that the Ku heterodimer functions in both 
DNA repair and in facilitating cell cycle arrest to ensure 
faithful repair has been completed.  To begin to address 
this possibility, we used a targeted knockdown approach 
to reduce the levels of Ku80 and p53 in WI38 
fibroblasts using shRNA vectors that we have found to 
be effective for reducing Ku80 and p53 levels in these 
cells (Figure 1A, Supplemental Figure 1) [8].  As a 
measure of genomic integrity and proper DNA repair, 
we examined the formation of micronuclei, which are 






































chromosomal damage. We predicted that decreasing Ku 
levels would increase micronuclei formation in human 
cells.  As predicted, more than 8-fold more cells with 
micronuclei were found in Ku80-depleted fibroblasts 
compared with control fibroblasts (Figure 1B,C). 
Interestingly, we found that targeting Ku80 resulted in 
an increased number of cells with micronuclei even in 
the absence of exogenous DNA damage (Figure 1B,C). 
As a positive control, we targeted p53 using shRNA, 
and the p53 knockdown cells also contained a higher 
percentage of micronuclei-positive cells confirming that 
genomic instability can arise upon inactivation of p53 
pathways (Figure 1A-C) [9].  As would be predicted, 
fibroblasts deficient in both p53 and Ku80 contained the 
most micronuclei-positive cells: 22% positive compared 
to 12% positive and 8% positive in p53-depleted and 

















































standard deviation is included. Statistics determined using Student’s T test are indicated by: *P<0.05; **P<0.01; ***P<0.001. Because we had previously noted that rodent cells 
express significantly lower levels of Ku80 than human 
cells [7], we examined micronuclei formation in mouse 
cells and compared this with human cells. We found 
that mouse cultures have a higher percentage of 
micronuclei-positive cells than human cultures 
following treatment with the DNA-damaging agent 



































Mouse and human fibroblasts exhibit differential 
responses to DNA damage 
 
During the evaluation of micronuclei, we examined 
53BP1 accumulation by immunofluorescence and noted 
a significant difference between mouse and human 
cells. After induction of DNA damage with 
neocarzinostatin, human fibroblasts contained more 
visible 53BP1 foci than mouse fibroblasts (compare 
human cells in right panel to mouse cells in left panel in 
Figure 3A). This difference in micronuclei after damage 
was confirmed by Western blot analysis using an 
antibody that was raised against an epitope of 53BP1 
that is conserved between mice and humans (Figure 
3B). The number of 53BP1 foci per cell was quantified, 
and although both mouse and human fibroblasts 
displayed an increase in 53BP1 focus formation after 
DNA damage induction, a higher percentage of human 
fibroblasts contained greater than twenty 53BP1 foci 
per cell by 72 hours following induction of DNA 
damage (Figure 3C).  These findings suggest that 
human fibroblasts display a more robust activation or 
upregulation of 53BP1 in response to DNA damage.  
 
Reducing 53BP1 in human cells changes their 
response to damage 
 
In order to determine whether human cells would 
display an increase in micronuclei formation similar to 
mouse cells if the levels of 53BP1 were reduced, WI38 
human fibroblasts were infected with one of two 
shRNA constructs targeting 53BP1 (sh53BP1 A or B), 
and these constructs led to either a 46% or a 13% 
reduction in 53BP1 protein levels (Figure 4A).  53BP1-
depleted WI38 human fibroblasts were treated with 
neocarzinostatin to induce DNA damage, and 
micronuclei were counted as a marker of unresolved 
DNA damage.  The amount of 53BP1 present in human 
fibroblasts appeared to be associated with the 
percentage of micronuclei-positive cells (Figure 4B,C).  
Fibroblasts treated with a scrambled control shRNA 
construct contained very few micronuclei (1.36% of 
cells with micronuclei), while fibroblasts with reduced 
53BP1 levels had significantly more micronuclei.   
Interestingly, the level of 53BP1 knockdown correlated 
with micronuclei, since fibroblasts treated with the 
shRNA construct producing the 46% knockdown 
(sh53BP1 A) contained 30.19% micronuclei-positive 
cells, while fibroblasts exhibiting the 13% knockdown 
in 53BP1 (sh53BP1 B) contained 13.73% micronuclei-
positive cells (Figure 4B,C).  Strikingly, the increase in 
micronuclei-positive cells upon 53BP1 reduction 
appeared to be independent of DNA damage, since 
similar numbers of micronuclei were observed in non-
damaged cells and the number of micronuclei did not 
increase further upon DNA damage induction (Figure 
4B,C).  
  
Cell cycle phase influences the response to DNA 
damage 
 
Previous work has shown that 53BP1 is involved in 
transduction of the DNA damage response during 
several phases of the cell cycle [10,11,12]. As a marker 
for dividing cells, we examined BrdU uptake in mouse 
and human cells following damage. We observed that 
virtually all cells that developed micronuclei were also 
positive for BrdU, confirming that after damage, 
Figure 2. Mouse cells have a significantly higher number of
micronuclei  in  comparison  with  human  cells  after  the  same
genotoxic damage. WI38 human and HME mouse fibroblasts
were  treated  with  1.5µg/mL  neocarzinostatin  (NCS)  for  2
hours in serum free medium, then cells were washed and fed
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formation (data not shown). To test the relative 
importance of cell cycle checkpoints, we arrested both 
mouse and human fibroblasts in G1 phase by serum 
starvation. Cells were then damaged with 
neocarzinostatin during G1 or released and damaged 
during S phase.  All cells were then allowed to recover 
from damage for three days. When mouse and human 
cells were damaged in G1 and released, there were 













































micronuclei in both cell types over three days after 
damage.  In contrast, when cells were damaged in S 
phase then released, 8-10% of mouse cells contained 
micronuclei by three days, while less than 1% of 
human cells contained micronuclei (Figure 5B).   
Additionally, Table 1 shows that when mouse and 
human cells were damaged in S phase, allowed to 
recover for 72 hours and then analyzed for their cell 
cycle position, human cells tended to arrest in G2 while 




































































































A link between species lifespan and damage 
resolution 
 
In order to determine whether the genetic instability 
observed in rodent cells correlated with species lifespan, 
we analyzed micronucleus formation after DNA 
damage in fibroblasts from several mammalian species 
with differing lifespan, which have been established 
under strictly standardized culture conditions [13].   
These species include, in order of increasing maximal 













































bovine, and human.  We found that fibroblast cultures 
from longer-lived species displayed a lower percentage 
of micronuclei-positive cells when compared with 
fibroblasts from shorter-lived species (Figure 6).   
Mouse fibroblasts contained the most micronuclei after 
damage (9.18% of cells), while human fibroblasts 
showed the fewest number of micronuclei-positive cells 
(1.34% of cells), and the percent of cells containing 
micronuclei demonstrates a negative correlate with 
































































































































  G1 
 
S G2 
Human untreated  68.2  9  22.8 
Human  neocarzinostatin  37.3 6.1 55.6 
Mouse  
untreated  
56.5 3.4 39.6 
Mouse  neocarzinostatin  57.3 7.4 34.8 





cells  per  treatment  and  time  point.  Non‐damaged  HME  and  WI38  fibroblasts  were  included  as  controls.
Differences between mouse and human cells statistically significant at P<0.01 are marked with two asterisks.  
   

























The DNA damage response and cell cycle checkpoints 
are closely linked, and there is substantial overlap of 
signaling factors in both processes.  In addition to the 
differences our laboratory has observed in Ku80 levels 
between mouse and human cells [7], we have now 
demonstrated differences in the accumulation of 53BP1 
between these two cell types.  Both under normal 
conditions and in response to treatment with a DNA 
damaging agent, we find that there is a more robust 
53BP1 foci response in human fibroblasts, which 
display higher numbers of 53BP1 foci over time, 
compared to mouse fibroblasts.  This observation 
suggests that 53BP1 recruitment may be linked to the 
differences in genome stability that characterize rodent 
and human cells.  This interpretation is consistent with 
previous studies that suggest that γH2AX serves to 
facilitate the accumulation of 53BP1 at damage foci to 
ensure proper cell cycle arrest [12]. Consistent with this 
concept, it has previously been shown that 53BP1-
deficient mouse fibroblasts cannot maintain G2/M arrest 
as efficiently after damage [14].  Interestingly, it has 
also been reported that 53BP1 foci may act to shield 
unresolved DNA lesions occurring as a result of 
replication stress and that 53BP1 foci may be 
maintained into subsequent cell cycles; these foci were 
associated with sites of frequent chromosome breaks 
such as fragile sites [5].  We noted that mouse cells 


























(labeled as control in Figure 3C), suggesting that mouse 
cells are more likely to harbor unresolved DNA lesions 
than human cells. However, following DNA damage, 
mouse cells mount a less robust response as evidenced 
by the reduced number of 53BP1 foci per cell, and 
presumably this reduced response leads to an increase in 
the number of cells that produce micronuclei relative to 
human cells. The link between micronuclei formation 
and 53BP1 levels is supported by the fact that a 
reduction in 53BP1 levels in human cells leads to a 
significant increase in micronuclei even in cells that 
have not been exposed to DNA damaging agents. 
 
The observation that reduced 53BP1 levels leads to 
increased micronuclei formation in the absence of DNA 
damage is somewhat surprising but this result is also 
consistent with an increase in the number of ultra fine 
DNA bridges that have been observed in SAOS cells 
targeted with siRNA directed against 53BP1 [5]. In 
addition, the use of siRNA against 53BP1 has shown 
that the protein is required for p53 activation and the 
induction of the G2/M and intra-S phase checkpoints in 
response to DNA damage [10], and we suspect that the 
increased accumulation of 53BP1 in human cells is due 
to the fact that checkpoint activation in response to 
damaged DNA is more efficient in human cells than in 
mouse cells.  The relationship between micronuclei 
formation in cultured fibroblasts and species lifespan 
suggests that the longer-lived species may have a more 
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DNA damage signals during most phases of the cell 
cycle, and 53BP1 colocalizes with phosphorylated 
H2AX and MDC1 at sites of DNA damage [10,14,15]. 
It may be that in the absence of exogenous DNA 
damage 53BP1 acts to activate G2 arrest following 
replication stress. Indeed, 53BP1 has been shown to 
facilitate NHEJ during S phase to resolve double-strand 
breaks induced by replication fork stalling [15].  
 
The possibility that 53BP1 action is required during S 
phase to prevent chromosome damage and micronuclei 
formation is further supported by the differential 
response to DNA damage depending upon the cell cycle 
phase during which damage was induced.  When human 
and mouse fibroblasts were damaged during S phase, 
mouse cells were more sensitive as demonstrated by 
increased micronuclei formation, and the G2 checkpoint 
arrest was less stringent as judged by the number of 
mouse cells that proceeded into G1 in the face of DNA 
damage (Figure 5, Table 1).   
 
In summary, we propose that differences in the 
accumulation of 53BP1 between mouse and human 
cells influences genomic stability in both the absence 
and presence of damaged DNA and forms at least part 
of the basis for the differences in genome stability 
observed between these two species.  
 
MATERIALS AND METHODS 
 
Cell Culture.  WI38 human fetal lung fibroblasts were 
obtained from Vincent J. Cristofalo.  Cells were 
maintained in Minimum Essential Medium 1X with 
Earle’s salts and L-glutamine (Mediatech, Manassas 
VA) containing 10% fetal bovine serum, 1X MEM 
vitamins, 1X MEM amino acids, and penicillin-
streptomycin (Mediatech).  Fibroblasts were passaged 
approximately once a week, and population doubling 
level was determined as previously described [16].   
HEK-293T cells for lentiviral production, purchased 
from ATCC (Manassas VA), were grown in DMEM 
containing 10% FBS.  Fibroblast cultures from mouse 
(noted as HME), little brown bat, dog, rabbit, and cow 
were produced and maintained as described previously 
[13].   
 
Chemicals.  All chemicals used were obtained from 
Sigma Aldrich (St. Louis, MO) unless otherwise noted.  
  
Lentiviral Production and Infection.  To produce the 
Ku80 or 53BP1 knockdown WI38 cells, we used a 
pLKO.1 lentiviral vector containing a short hairpin 
RNA.  The Ku80 shRNA construct was obtained from 
Sigma Aldrich (MISSION
® TRC shRNA 
TRCN0000039840) and targeted the 5’ coding region of 
the human Ku80 messenger RNA.  Two 53BP1 shRNA 
constructs, also purchased from Sigma Aldrich, targeted 
the 5’ coding region of the human 53BP1 messenger 
RNA (MISSION
® TRC shRNA TRCN0000018866 and 
TRCN0000018869).  Scrambled shRNA plasmid #1864 
(Addgene, Cambridge MA) had the following hairpin 
sequence: CCTAA GGTTA AGTCG CCCTC GCTCT 
AGCGA GGGCG ACTTA ACCTT AGG [17].  To 
produce p53-depleted fibroblasts, five p53 shRNA 
constructs were tested, and the construct providing the 
most robust knockdown was used (MISSION
® TRC 
shRNA TRCN0000003756) (Supplemental Figure 1).   
Cells were infected with shRNA viral supernatant along 
with 10ug/mL polybrene (American Bioanalytical, 
Natick MA) for 24 hours followed by a 72-hour 
selection with 2ug/mL puromycin (Mediatech) to 
eliminate uninfected cells. 
 
SDS-PAGE and Western blotting.  For SDS-PAGE, 30 
micrograms of cell extracts in RIPA buffer (50mM Tris, 
150mM NaCl, 1% NP-40, 0.1% SDS, 0.5% sodium 
deoxycholate, 1mM PMSF, 1 ug/mL leupeptin, 1 ug/mL 
pepstatin) were loaded onto 8% polyacrylamide gels.   
Gels were transferred to nitrocellulose membranes and 
blocked for 1 hour in 5% milk in Tris-buffered saline 
containing 0.1% Tween-20 (TBST).  Membranes were 
incubated with anti-53BP1 (Novus Biologicals, 
Littleton CO), anti-p53 (Santa Cruz Biotechnologies, 
Santa Cruz CA), anti-Ku80 (Abcam, Cambridge MA), 
or anti-β-actin (Sigma Aldrich) in 5% milk TBST 
overnight with shaking.  Membranes were incubated for 
1 hour with goat anti-mouse-HRP or goat anti-rabbit-
HRP (Millipore, Billerica MA) in 5% milk TBST.   
Blots were washed in TBST and incubated with ECL 
Plus chemiluminescent substrate (GE Healthcare 
BioSciences, Piscataway NJ) for 5 minutes before 
developing.  Densitometry measurements were captured 
using the ChemiDoc station and software (Biorad, 
Hercules CA).  All densitometric measurements were 
normalized to loading controls.     
      
53BP1 Immunofluorescence.  WI38 human and HME 
mouse fibroblasts were seeded onto glass coverslips and 
treated with 1.5 ug/mL neocarzinostatin for two hours.  
Following treatment, cells were fixed immediately or at 
indicated times after damage in 4% paraformaldehyde 
for ten minutes and permeabilized in 0.2% Triton X-100 
in PBS for one minute.  Cells were washed once in PBS 
and blocked for thirty minutes in 4% BSA in PBS 
containing Tween-20 (PBST), after which they were 
incubated in anti-53BP1 in 1% BSA-PBST buffer for 2 
hours at 37°C in a humidified chamber.  Slides were 
washed three times in PBST and incubated in 
AlexaFlour555-conjugated goat anti-rabbit secondary 
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for one hour to label 53BP1. Cells were washed three 
times, dehydrated with increasing ethanol 
concentrations, stained with DAPI, and mounted with 
Vectashield (Vector Laboratories, Burlingame CA) 
before visualizing.  Images were captured using the 
Olympus BX61 microscope and Hamamatsu ORCA-ER 
camera and analyzed using Slidebook software.   
 
Immunofluorescence for micronuclei.  E i t h e r  
asynchronous cells or populations synchronized in G1 or 
S phase were treated with 1.5 ug/mL neocarzinostatin 
for two hours.  To synchronize in G1, cells were washed 
twice in 1X PBS and incubated for 72 hours in serum-
free growth medium.  Cells were either fixed and 
stained with DAPI right away or allowed to recover in 
growth medium for the indicated amounts of time 
represented in the figures.  The cells were fixed in 4% 
paraformaldehyde for ten minutes and permeabilized in 
0.2% Triton X-100 in PBS for one minute.  The fixed 
c e l l s  w e r e  w a s h e d  w i t h  P B S ,  d e h y d r a t e d  w i t h  7 0 % ,  
90%, and 100% ethanol for three minutes each, and 
mounted in Vectashield containing DAPI.  Cells were 
considered micronucleus-positive if they contained at 
least one micronucleus.  For each time point and 
treatment, at least 400 cells were scored as positive or 
negative for micronuclei. Images were captured using 
the Olympus BX61 microscope and Hamamatsu 
ORCA-ER camera and analyzed using Slidebook 
software.  
 
Statistical Analysis.  Statistical significance was 
measured using one-or two-tailed Student’s T test or 
Fisher’s Exact test.  Significant changes are indicated 
with asterisks in the appropriate figures. Regression 
analysis and Pearson correlation were performed using 
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